These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1672101)

  • 21. Nitric oxide as a signal in thyroid.
    Esteves RZ; van Sande J; Dumont JE
    Mol Cell Endocrinol; 1992 Dec; 90(1):R1-3. PubMed ID: 1284493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER; Marletta MA
    Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins.
    Ignarro LJ
    Semin Hematol; 1989 Jan; 26(1):63-76. PubMed ID: 2564216
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase.
    Boulton CL; Southam E; Garthwaite J
    Neuroscience; 1995 Dec; 69(3):699-703. PubMed ID: 8596640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung.
    Ignarro LJ; Degnan JN; Baricos WH; Kadowitz PJ; Wolin MS
    Biochim Biophys Acta; 1982 Sep; 718(1):49-59. PubMed ID: 6128034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in the subcellular distribution of Guanylate cyclase and its responsiveness to nitric oxide in diethylstilbestrol-induced renal tumors.
    Braughler JM; Gilloteaux J; Steggles AW
    Cancer; 1982 Jul; 50(1):78-84. PubMed ID: 6123381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme.
    Ignarro LJ; Wood KS
    Biochim Biophys Acta; 1987 Apr; 928(2):160-70. PubMed ID: 2882783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble guanylate cyclase.
    Poulos TL
    Curr Opin Struct Biol; 2006 Dec; 16(6):736-43. PubMed ID: 17015012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanylate cyclase and the .NO/cGMP signaling pathway.
    Denninger JW; Marletta MA
    Biochim Biophys Acta; 1999 May; 1411(2-3):334-50. PubMed ID: 10320667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis.
    Banick PD; Chen Q; Xu YA; Thom SR
    J Cell Physiol; 1997 Jul; 172(1):12-24. PubMed ID: 9207921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.
    Pou S; Pou WS; Rosen GM; el-Fakahany EE
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):547-52. PubMed ID: 1671745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
    Mülsch A; Busse R; Bassenge E
    Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP.
    Cary SP; Winger JA; Marletta MA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13064-9. PubMed ID: 16131543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine 3',5'-monophosphate formation by preparations of rat liver soluble guanylate cyclase activated with nitric oxide, nitrosyl ferroheme, S-nitrosothiols, and other nitroso compounds.
    McNamara DB; Kadowitz PJ; Hyman AL; Ignarro LJ
    Can J Physiol Pharmacol; 1980 Dec; 58(12):1446-56. PubMed ID: 6113040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of some of the biological effects of nitric oxide and its role in cell signaling.
    Murad F
    Biosci Rep; 2004; 24(4-5):452-74. PubMed ID: 16134022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of nitric oxide-sensitive guanylyl cyclase.
    Friebe A; Koesling D
    Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.